Genmab A/S ADR is now listed on the NASDAQ stock exchange.
8 reports, 2 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Genmab A/S ADR is now listed on the NASDAQ stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- NervGen Pharma Corp. began utilizing Nasdaq for its at-the-market program.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.
- Midwestone Financial Group (Carter Bank & Trust) is listed on Nasdaq and is receiving analyst ratings from MarketBeat.
- Maase Inc. has been listed on the Nasdaq stock exchange.
- Netgear was listed on the Nasdaq stock exchange on October 12, 2026.